SNO 2020: Nivolumab + Hypofractionated Reradiation + Bevacizumab Shows Promise in Recurrent MGMT-Methylated GBM
Patients have tolerated the treatment well.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.